Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Enzon seeks approval to test cancer drug
“The filing of HIF-1alpha, our fourth IND submission in 2006, demonstrates our strong commitment to delivering on our promises and developing a differentiated cancer portfolio,” said Jeffrey Buchalter,
“The filing of HIF-1alpha, our fourth IND submission in 2006, demonstrates our strong commitment to delivering on our promises and developing a differentiated cancer portfolio,” said Jeffrey Buchalter,
The MGX-006 program is being supported via a co-development agreement between Victory and its technology partner signed in August of 2006. “Many patients who experience pain also experience
The research collaboration will include ETI-211, an HP antibody for the treatment of MRSA infections. Under the terms of the agreement Elusys and Pfizer will collaborate on determining
Cethrin was designed to specifically target the cellular response to an acute spinal cord injury (SCI), promote the re-growth of injured axons, and restore sensory and motor function.
The broad partnership centers on five drug candidates that Synosis will acquire from Roche, including four phase I molecules, which target the central nervous system. Roche had discontinued
Syntonix technology has the potential to enhance the delivery of biopharmaceuticals through less frequent injections or by enabling pulmonary delivery. Syntonix’s lead product, FIX:Fc, is a being developed
The trial will be conducted in accordance with a special protocol assessment and AnGes MG will fund the clinical trial under a collaborative agreement with Vical. “There is
The study, designed to evaluate the safety and efficacy of the once-daily dopamine agonist rotigotine, found that the drug significantly improved symptoms in the patients taking part versus
Applications of the ddRNAi technology for research activities have been licensed exclusively by Sigma- Aldrich from Benitec Limited of Australia. Financial details of the deal were not disclosed.
Scientists at Yale School of Medicine have reported that estrogen is a strong regulator of energy metabolism through the brain, after studying mice with mutations in leptin or